Helena Sanchez Coloma, Associate Director of MedNews Week, NSHSS Collegiate Council Executive Board Co-Vice President of Member Engagement, shared on LinkedIn:
“According to the National Organization for Rare Disorders, chronic myeloid leukemia (CML), a rare blood disease, has an annual incidence of 1 to 2 cases per 100,000 people.
CML care is moving beyond disease control toward more individualized treatment.
MedNews Week x OncoDaily’s latest Keynote, ‘The CML Evolution: Mastering Modern Algorithms in Chronic Myeloid Leukemia,’ features Dr. Jorge Eduardo Cortes.
Dr. Cortes is a leader in leukemia research with much experience leading more than 90 Phase I–III clinical trials. In this Keynote, Dr. Cortes discusses how CML treatment has evolved and selecting therapies based on disease response and patient goals.
This Keynote can help everyone in all stages of training deepen their understanding of modern CML management.
Thank you very much to Dr. Cortes for sharing your expertise with our global audience, and to Drs. Yan Leyfman and Chandler Park for fostering accessible, collaborative medical education.”
You can also read: BCR::ABL1-Rearranged Chronic Myeloid Leukemia: Molecular Basis, TKI Resistance and Emerging Therapies
